isoniazid has been researched along with Myasthenia Gravis in 1 studies
Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 47-year-old woman who had been treated for systemic lupus erythematosus (SLE) with myasthenia gravis (MG) was admitted to our hospital with acute onset of severe anemia after administration of isoniazid." | 7.76 | Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis. ( Eguchi, K; Ida, H; Imanishi, D; Kawakami, A; Motomura, M; Nakamura, H; Okada, A; Yamasaki, S, 2010) |
| "A 47-year-old woman who had been treated for systemic lupus erythematosus (SLE) with myasthenia gravis (MG) was admitted to our hospital with acute onset of severe anemia after administration of isoniazid." | 3.76 | Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis. ( Eguchi, K; Ida, H; Imanishi, D; Kawakami, A; Motomura, M; Nakamura, H; Okada, A; Yamasaki, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, H | 1 |
| Okada, A | 1 |
| Kawakami, A | 1 |
| Yamasaki, S | 1 |
| Ida, H | 1 |
| Motomura, M | 1 |
| Imanishi, D | 1 |
| Eguchi, K | 1 |
1 other study available for isoniazid and Myasthenia Gravis
| Article | Year |
|---|---|
Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis.
Topics: Antitubercular Agents; Cyclosporine; Drug Therapy, Combination; Erythroblasts; Female; Humans; Immun | 2010 |